BioWorld

March 12, 2003

Seeking Pipeline Funds, Inspire Files For Estimated $56M Offering

Inspire Pharmaceuticals Inc. said it intends to publicly offer 4 million shares of common stock to help fund its drug discovery projects and possibly to pay the cost of hiring a 60-person sales force. (BioWorld Today) Read More

European Sector Rallying Cry: Comebacks, Consolidation

Hitherto Ignored, Astrocytes Are Brain Cells That Attack A-Beta In Alzheimer's Neuronal Plaques

Peptimmune Nets $41.2 Million In Series A Financing Round

Other News To Note

U.S. Patent Disclosures

Today's news in brief

BioWorld

BioWorld briefs for July 14, 2026.

AI-generated illustration of a neuron with tau protein aggregation

AAIC 2026: Age of amyloid is being joined by time of tau

BioWorld

The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

NRF2 activators reported in Vailima Peninsula patent

BioWorld Science

Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 14, 2026